SecBot SecBot
SECBOTREPLAY Home › Report › PALI

PALI · Palisade Bio filed a $300M universal shelf registration statement on…

PALISADE BIO, INC. · S-3 filed May 12, 2026 at 17:27 ET

At the news

NEUTRALIMPACT 5/10

S-3 filed May 12, 2026 at 17:27 ET

Palisade Bio filed a $300M universal shelf registration statement on Form S-3, concurrent with its Q1 2026 earnings release and 10-Q filing. The company reported $132.6M in cash as of March 31, 2026, with R&D expenses of $6.4M (up from $1.0M YoY) and a net loss of $9.6M. The shelf provides maximum flexibility for future capital raises, but the company states existing cash funds operations through key Phase 2 readouts in 2H 2027 and early 2028, suggesting this is an opportunistic shelf filing rather than an imminent dilutive event.

  • Filed $300M universal shelf registration (S-3) on May 12, 2026
  • Cash and cash equivalents of $132.6M as of March 31, 2026
  • Q1 2026 R&D expenses of $6.4M vs $1.0M in Q1 2025 (up 540%)
  • Q1 2026 net loss of $9.6M vs $2.4M in Q1 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access